No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans

BACKGROUND Association studies between marker alleles at the D2 dopamine receptor gene (DRD2) and various psychiatric illnesses have produced conflicting results. Reports of allelic associations were originally made with alcoholism, but were then extended to other psychiatric disorders; there has been a series of positive reports suggesting an association between DRD2 alleles and substance dependence in European-American (EA) subjects. METHODS In an attempt to replicate the reported association between DRD2 alleles, substance dependence, and severity of substance dependence, we studied allele frequencies for three polymorphic DRD2 systems (TaqI "A," "B," and "D") in 96 EA and 77 African-American (AA) cocaine-dependent subjects, and 87 EA and 45 AA control subjects. To increase our power to detect such an association and to better understand any association detected, we also constructed three-locus haplotypes and compared haplotype frequencies. RESULTS For both the EA and AA samples, there were no significant differences in allele frequency between substance-dependent and control subjects for any of the three DRD2 polymorphic systems studied. There were also no significant differences in haplotype frequency between substance-dependent and control subjects for either EA or AA subjects; and, finally, there were no significant differences in "A" or "B" system allele frequency by severity. There were, however, significant differences between EAs and AAs. CONCLUSIONS Our data do not support an association between DRD2 alleles or haplotypes and cocaine dependence, in EA or AA subjects. Moreover, DRD2 alleles are not associated with severity of cocaine dependence in this sample.

[1]  G. Edwards,et al.  Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. , 1981, Bulletin of the World Health Organization.

[2]  R. Lewontin,et al.  On measures of gametic disequilibrium. , 1988, Genetics.

[3]  E. Smeraldi,et al.  Use of polymerase chain reaction nad denaturing gradient gel electrophoresis to identify polymorphisms in three exons of dopamine D2 receptor gene in schizophrenic and delusional patients. , 1992, Neuropsychobiology.

[4]  D. Grandy,et al.  Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. , 1991, Genomics.

[5]  K. Kidd,et al.  No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. , 1991, JAMA.

[6]  George R. Uhl,et al.  D2 dopamine receptor Gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers , 1996, Biological Psychiatry.

[7]  J. Long,et al.  An E-M algorithm and testing strategy for multiple-locus haplotypes. , 1995, American journal of human genetics.

[8]  K. Jellinger,et al.  Schizophrenia: Normal Sequence in the Dopamine D2 Receptor Region that Couples to G-Proteins. DNA Polymorphisms in D2 , 1993, Neuropsychopharmacology.

[9]  N Risch,et al.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.

[10]  J. Gelernter,et al.  Candidate Genes and Psychiatric Genetics: Tomorrow Never Knows , 1997 .

[11]  D. Grandy,et al.  Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. , 1991, Genomics.

[12]  D. Comings,et al.  The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.

[13]  D. Comings,et al.  Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication , 1996, Biological Psychiatry.

[14]  R. Spitzer,et al.  Proposed changes in DSM-III substance use disorders: description and rationale. , 1986, The American journal of psychiatry.

[15]  E. Juengst.  Priorities in professional ethics and social policy for human genetics. , 1991, JAMA.

[16]  G. Uhl,et al.  Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. , 1993, Human heredity.

[17]  D. Comings,et al.  A study of the dopamine D2 receptor gene in pathological gambling. , 1996, Pharmacogenetics.

[18]  Cloninger Cr,et al.  D2 dopamine receptor gene is associated but not linked with alcoholism. , 1991 .

[19]  N. Risch,et al.  Alcoholism and the D2 Dopamine Receptor Gene-Reply , 1993 .

[20]  M. Krebs,et al.  Genetic vulnerability to drug abuse , 2000, European Psychiatry.

[21]  K. Kidd,et al.  Population frequencies of the A1 allele at the dopamine D2 receptor locus , 1993, Biological Psychiatry.

[22]  R. Cadoret,et al.  Adoption study demonstrating two genetic pathways to drug abuse. , 1995, Archives of general psychiatry.

[23]  M. Anglin,et al.  The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusers , 1996, Biological Psychiatry.

[24]  W. Berrettini,et al.  Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans , 1996, Biological Psychiatry.

[25]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[26]  K. Blum,et al.  No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. , 1994, JAMA.

[27]  D. Goldman,et al.  DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. , 1993, Alcoholism, clinical and experimental research.

[28]  Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990 .

[29]  A. Rolfs,et al.  Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians. , 1996, Gene.

[30]  C. Robert Cloninger,et al.  Linkage disequilibria at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. , 1994, Genomics.

[31]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with cocaine dependence. , 1993, Drug and alcohol dependence.

[32]  K. Kidd,et al.  DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. , 1996, Alcoholism, clinical and experimental research.

[33]  M. Itokawa,et al.  Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese , 1993, Biological Psychiatry.

[34]  D. Grandy,et al.  PCR detection of the TaqA RFLP at the DRD2 locus. , 1993, Human molecular genetics.

[35]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[36]  A J Pakstis,et al.  Evolution of haplotypes at the DRD2 locus. , 1995, American journal of human genetics.

[37]  D. Comings,et al.  The dopamine D2 receptor gene: a genetic risk factor in substance abuse. , 1994, Drug and alcohol dependence.

[38]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[39]  J. Blouin,et al.  Computerized administration of the diagnostic interview schedule , 1988, Psychiatry Research.

[40]  R Pickens,et al.  Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. , 1992, Archives of general psychiatry.